Recombinant multi-species Collagen Type I/COL1A1 protein for cell curture, in vitro study, in vivo study, benchmark, drug discovery & MOA research and positive control for the diagnosis
Genemedi produces recombinant Human, Cynomolgus/ Rhesus macaque, Rat, Mouse, Feline, Canine, Bovine, Equine Collagen Type I/COL1A1 protein for cell curture, in vitro study, in vivo study, benchmark, drug discovery & MOA research and positive control for the diagnosis.
This gene encodes the pro-alpha1 chains of type I collagen whose triple helix comprises two alpha1 chains and one alpha2 chain. Type I is a fibril-forming collagen found in most connective tissues and is abundant in bone, cornea, dermis and tendon. Mutations in this gene are associated with osteogenesis imperfecta types I-IV, Ehlers-Danlos syndrome type VIIA, Ehlers-Danlos syndrome Classical type, Caffey Disease and idiopathic osteoporosis. Reciprocal translocations between chromosomes 17 and 22, where this gene and the gene for platelet-derived growth factor beta are located, are associated with a particular type of skin tumor called dermatofibrosarcoma protuberans, resulting from unregulated expression of the growth factor. Two transcripts, resulting from the use of alternate polyadenylation signals, have been identified for this gene. [provided by R. Dalgleish, Feb 2008]
The Alternative Names of target: Alpha-1 type I collagen,CAFYD,COL1A1,COLIA1,Col1a-1,Col1a1,Cola-1,Cola1,Collagen Type I,Collagen alpha-1(I) chain,EDSARTH1,EDSC,Mov-13,Mov13,OI1,OI2,OI3,OI4
Go
to Collagen Type I/COL1A1 products collection
>>
(antibodies,
antigen, VLP, mRNA, ORF viral vector, etc)
Product information
| Catalog No. | Product Name | Species Reactivity |
|---|---|---|
| GM-Tg-hg-SE0103-Ag-1/ GM-Tg-hg-SE0103-Ag-2 | Human Collagen Type I/COL1A1 protein | Human |
| GM-Tg-rg-SE0103-Ag-1/ GM-Tg-rg-SE0103-Ag-2 | Rat Collagen Type I/COL1A1 protein | Rat |
| GM-Tg-mg-SE0103-Ag-1/ GM-Tg-mg-SE0103-Ag-2 | Mouse Collagen Type I/COL1A1 protein | Mouse |
| GM-Tg-cynog-SE0103-Ag-1/ GM-Tg-cynog-SE0103-Ag-2 | Cynomolgus/Rhesus macaque Collagen Type I/COL1A1 protein | Cynomolgus/ Rhesus macaque |
| GM-Tg-felg-SE0103-Ag-1/ GM-Tg-felg-SE0103-Ag-2 | Feline Collagen Type I/COL1A1 protein | Feline |
| GM-Tg-cang-SE0103-Ag-1/ GM-Tg-cang-SE0103-Ag-2 | Canine Collagen Type I/COL1A1 protein | Canine |
| GM-Tg-bovg-SE0103-Ag-1/ GM-Tg-bovg-SE0103-Ag-2 | Bovine Collagen Type I/COL1A1 protein | Bovine |
| GM-Tg-equg-SE0103-Ag-1/ GM-Tg-equg-SE0103-Ag-2 | Equine Collagen Type I/COL1A1 protein | Equine |
Size: 1mg | 10mg | 100mg
Product Description
| Catalog No. |
GM-Tg-hg-SE0103-Ag-1/ GM-Tg-hg-SE0103-Ag-2;
GM-Tg-rg-SE0103-Ag-1/ GM-Tg-rg-SE0103-Ag-2;
GM-Tg-mg-SE0103-Ag-1/ GM-Tg-mg-SE0103-Ag-2; GM-Tg-cynog-SE0103-Ag-1/ GM-Tg-cynog-SE0103-Ag-2; GM-Tg-felg-SE0103-Ag-1/ GM-Tg-felg-SE0103-Ag-2; GM-Tg-cang-SE0103-Ag-1/ GM-Tg-cang-SE0103-Ag-2; GM-Tg-bovg-SE0103-Ag-1/ GM-Tg-bovg-SE0103-Ag-2; GM-Tg-equg-SE0103-Ag-1/ GM-Tg-equg-SE0103-Ag-2 |
| Products Name | Collagen Type I/COL1A1 protein |
| Species | Human, Cynomolgus/ Rhesus macaque, rat, mouse, Feline, Canine, Bovine, Equine |
| Target Name | Collagen Type I/COL1A1 |
| Protein Sub-location | Secreted Protein/Potential Cytokines |
| Isotypes | Recombinant protein |
| Expression platform | Mammalian cell |
| Bioactivity validation | Affintiy&bioactivity validated by ELISA, cell culture validated. |
| Tag | His |
| Products description | Recombinant Human, Cynomolgus/ Rhesus macaque, Rat, Mouse, Feline, Canine, Bovine, Equine Collagen Type I/COL1A1 protein was expressed in mammalian cell expression system and is expressed with 6 HIS tag at the C-terminus for cell culture, ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic). |
| Purity | Purity: ≥95% (SDS-PAGE) |
| Application | In vitro study, in vivo study, benchmark, positive control for the diagnosis. Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research. |
| Formulation & Reconstitution |
Lyophilized from GM's Protein Stability Buffer2
(PSB2,Confidential Ingredients) or PBS
(pH7.4); For PSB2, reconstituted with 0.9% sodium chloride; For PBS, reconstituted with ddH2O. |
| Storage | Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles. |
Reference
About Gmab

GMab, developed by GeneMedi, constitutes an
advanced library of recombinant
monoclonal antibodies, each meticulously
designed to target specific molecular
entities. Leveraging the sophisticated
capabilities of GM’s Taurus™ and LIBRA™
platforms, GMab synthesizes antibodies
characterized by high binding affinity,
exceptional physicochemical stability, and
optimal developability profiles.
Through
expression in mammalian cell lines, GMab has
been established as a paradigmatic
reference antibody. It holds significance in
myriad domains of biological drug
discovery, encompassing cellular cultivation,
innovative assay methodologies,
strategic animal model systematization, in-depth
pharmacokinetic & pharmacodynamic
(PK/PD) modeling, and intricate mechanism of
action (MOA) investigations.